Bridging the Gap Between Participants and Clinical Trials
GS-US-563-5925: People With HIV-1 Who Are Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir
CONDITION
Other
GENDER
All
AGE GROUP
From 18
and above
STATUS
Active, not recruiting
A Phase 3, Randomized, Active-controlled, Double-blind Study to Evaluate a Switch to an Oral Weekly Islatravir/Lenacapavir Regimen in People With HIV-1 Who Are Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir (B/F/TAF)
Studies Contact Form
Approved By: Bellberry limited
Clinical Trial Registry Link:
Notice: Function WP_Scripts::add was called incorrectly. The script with the handle "gforms_recaptcha_frontend" was enqueued with dependencies that are not registered: gforms_recaptcha_recaptcha. Please see Debugging in WordPress for more information. (This message was added in version 6.9.1.) in /srv/users/australianclinicaltrials/apps/australianclinicaltrials/public/wp-includes/functions.php on line 6260